focus -WSS

focus

author：knowledge 2025-09-27 23:32:45 - browse：17

The Amgen booth at ESMO in Madrid. Andrew Joseph/STAT

MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug.

The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also published Friday in the New England Journal of Medicine.

“It’s a single arm study, but the results are amazing,” said Silke Gillessen, the scientific chair of ESMO 2023 and an oncologist at the Oncology Institute of Southern Switzerland, noting that advances in small cell lung cancer have been slow to come.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Superbugs, antibiotic resistance get scrutiny in congress

knowledge

WSS

Women's World Cup brings attention to abuse in soccer

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Britney Spears to release memoir, 'The Woman In Me,' later this year

How are insurers handling Leqembi and related scans?

Grail's uphill battle for Medicare to cover its cancer screening test

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

entertainment

focus

explore

Bright Health sells Medicare Advantage business to Molina

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Activists slam private health insurers over coverage restrictions

What to expect as Trump is arraigned on his Jan 6. indictment

DIEP, the 'gold standard' of breast reconstruction, is under threat

Inflation cooled significantly in June, bringing price hikes close to normal levels

Medicare proposal to cover medical devices draws a mixed reaction

‘Oppenheimer’ and the risks of AI in health care

The high cost of giving birth even with insurance

Amazon expands telehealth clinic nationwide

hotspot

5 important ways Henrietta Lacks changed medical science

The debate over Covid

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Sickle cell gene therapy cures need to be accessible in Africa

Digital health funding stays low as a new reality sets in

Digital health funding stays low as a new reality sets in

knowledge

hotspot

knowledge

entertainment